XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
124 hedge funds and large institutions have $807M invested in Intersect ENT, Inc in 2021 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less call options, than puts
Call options by funds: $262K | Put options by funds: $1.91M
Holders
124
Holding in Top 10
1
Calls
$262K
Puts
$1.91M
Top Buyers
| 1 | +$69.6M | |
| 2 | +$61.4M | |
| 3 | +$39.2M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$37.9M |
| 5 |
Morgan Stanley
New York
|
+$15.2M |
Top Sellers
| 1 | -$82.1M | |
| 2 | -$59.5M | |
| 3 | -$19.2M | |
| 4 |
Jennison Associates
New York
|
-$15.5M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$12M |